Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - glycine; citric acid monohydrate; glucose anhydrous; potassium citrate; potassium phosphate monobasic; sodium chloride - oral solution/suspension - glycine amino acid-glycine active 6.18 g/sa; citric acid monohydrate acid-general active 0.48 g/sa; glucose anhydrous carbohydrate active 44.61 g/sa; potassium citrate mineral-potassium active 0.12 g/sa; potassium phosphate monobasic mineral-potassium active 4.08 g/sa; sodium chloride mineral-sodium-salt active 8.58 g/sa - nutrition & metabolism - calf | cat | dog | horse foal | lamb | pigs | beef calf | bitch | boar | bovine | calf - poddy | calf - preweaning | calf - suck - dehydration | diarrhoea | scours | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | postweaning scours | prophylactic | scours | selenium responsive scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours

Yeni Zelanda - İngilizce - Ministry for Primary Industries

agrihealth nz limited - sodium bicarbonate; potassium chloride; sodium chloride; malto-dextrine; potassium phosphate monobasic; dextrose; dextrin; glycine; potassium citrate - sodium bicarbonate 65.71 g/kg; potassium chloride 10 g/kg; sodium chloride 88.57 g/kg; malto-dextrine 35.72 g/kg; potassium phosphate monobasic 28.43 g/kg; dextrose 571.4 g/kg; dextrin 107.18 g/kg; glycine 91.53 g/kg; potassium citrate 1.44 g/kg - oral nutrient/electrolyte

ABD - İngilizce - NLM (National Library of Medicine)

baxter healthcare corporation - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838), sodium phosphate, dibasic, heptahydrate (unii: 70wt22sf4b) (sodium cation - unii:lyr4m0nh37, phosphate ion - unii:nk08v8k8hr), potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr - sodium chloride 800 mg in 100 ml - isotonic solution for irrigation only. not for injection.

Kanada - İngilizce - Health Canada

quali-tech inc. - calcium chloride; calcium d-pantothenate; magnesium sulfate; potassium phosphate monobasic; sodium phosphate monobasic; potassium citrate; potassium chloride; glycine; sodium chloride; dextrose; ascorbic acid - powder for solution - .015%; .015%; .015%; .38%; .86%; 1.715%; 2.225%; 9.37%; 11.88%; 65.735%; .05% - calcium chloride .015%; calcium d-pantothenate .015%; magnesium sulfate .015%; potassium phosphate monobasic .38%; sodium phosphate monobasic .86%; potassium citrate 1.715%; potassium chloride 2.225%; glycine 9.37%; sodium chloride 11.88%; dextrose 65.735%; ascorbic acid .05% - cattle

Kanada - İngilizce - Health Canada

quali-tech inc. - ascorbic acid; calcium chloride; calcium d-pantothenate; magnesium sulfate; dextrose; potassium phosphate monobasic; sodium phosphate monobasic; potassium citrate; potassium chloride; glycine; sodium chloride - powder for solution - .05%; .015%; .015%; .015%; 65.445%; .38%; .86%; 1.715%; 2.225%; 9.37%; 11.88% - ascorbic acid .05%; calcium chloride .015%; calcium d-pantothenate .015%; magnesium sulfate .015%; dextrose 65.445%; potassium phosphate monobasic .38%; sodium phosphate monobasic .86%; potassium citrate 1.715%; potassium chloride 2.225%; glycine 9.37%; sodium chloride 11.88% - cattle

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

elanco animal health, eli lilly and company limited - sodium chloride, aminoacetic acid, potassium phosphate monobasic, sodium citrate acid, potassium citrate, sodium citrate, glucose monohydrate - powder for oral solution - unknown - oral electrolytes and carbohydrates - bovine - electrolytes

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

elanco animal health, eli lilly and company limited - sodium chloride, aminoacetic acid, potassium phosphate monobasic, sodium citrate acid, potassium citrate, sodium citrate, glucose monohydrate - powder for oral solution - oral electrolytes and carbohydrates - cattle - electrolytes

Kanada - İngilizce - Health Canada

canadian custom packaging company - chlorobutanol; sodium phosphate dibasic; potassium phosphate monobasic - liquid - 1.41875kg; 35.69575kg; 34.3905kg - chlorobutanol 1.41875kg; sodium phosphate dibasic 35.69575kg; potassium phosphate monobasic 34.3905kg - antipruritics and local anesthetics

ABD - İngilizce - NLM (National Library of Medicine)

baxter healthcare corporation - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - potassium chloride 29.8 g in 1000 ml - potassium chloride injection is indicated in the treatment of potassium deficiency states when oral replacement is not feasible. this highly concentrated, ready-to-use potassium chloride injection is intended for the maintenance of serum k+ levels and for potassium supplementation in fluid restricted patients who cannot accommodate additional volumes of fluid associated with potassium solutions of lower concentration. when using these products, these patients should be on continuous cardiac monitoring and frequent testing for serum potassium concentration and acid-base balance. potassium chloride injection is contraindicated in patients with:

ABD - İngilizce - NLM (National Library of Medicine)

strides pharma inc. - potassium citrate (unii: ee90oni6ff) (anhydrous citric acid - unii:xf417d3psl) - potassium citrate 5 meq - potassium citrate is indicated for the management of renal tubular acidosis [see clinical studies (14.1)] . potassium citrate is indicated for the management of hypocitraturic calcium oxalate nephrolithiasis [see clinical studies (14.2)] . potassium citrate is indicated for the management of uric acid lithiasis with or without calcium stones [see clinical studies (14.3)] . potassium citrate extended-release tablets are contraindicated: • in patients with hyperkalemia (or who have conditions predisposing them to hyperkalemia), as a further rise in serum potassium concentration may produce cardiac arrest. such conditions include: chronic renal failure, uncontrolled diabetes mellitus, acute dehydration, strenuous physical exercise in unconditioned individuals, adrenal insufficiency, extensive tissue breakdown or the administration of a potassium-sparing agent (such as triamterene, spironolactone or amiloride). • in patients in whom there is cause for arrest or delay in tablet passage through the gastrointestinal